Regulation of inflammation-related genes in human adipose tissue

Journal of Internal Medicine

Volumn 262, Issue 4, 2007, Pages 422-430

  Clement, K ^a,b,c   Langin, D ^a,d,e,f  

^a INSERM   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c HÔTEL DIEU   (France)

^d UNIVERSITÉ DE TOULOUSE   (France)

^e TOULOUSE UNIVERSITY HOSPITAL   (France)

^f Inserm   (Czech Republic)

Author keywords

Adipose tissue; Gene expression; Inflammation; Macrophages; Obesity

Indexed keywords

AMYLOID A PROTEIN; CATHEPSIN;

ADIPOSE TISSUE; CALORIC RESTRICTION; CARDIOVASCULAR SYMPTOM; CHRONIC INFLAMMATION; COMORBIDITY; CONFERENCE PAPER; EXERCISE; GENE EXPRESSION; HUMAN; INTRAABDOMINAL FAT; MACROPHAGE; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUBCUTANEOUS FAT; WEIGHT REDUCTION;

ADIPOSE TISSUE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGES; OBESITY; PANNICULITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548655196     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2007.01851.x     Document Type: Conference Paper

References (66)

1. Frohlich M, Imhof A, Berg G et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 2000 23 : 1835 9.
2. Schindler TH, Cardenas J, Prior JO et al. Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol 2006 47 : 1188 95.
3. Festa A, D'Agostino R Jr., Howard G et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000 102 : 42 7.
4. Pai JK, Pischon T, Ma J et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004 351 : 2599 610.
5. Ridker PM. C-reactive protein, inflammation, and cardiovascular disease: clinical update. Tex Heart Inst J 2005 32 : 384 6.
6. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001 9 : 414 7.
7. Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006 97 : 3A 11A.
8. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004 89 : 2548 56.
9. Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2000 11 : 212 7.
10. Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 2003 100 : 7265 70.
11. Maachi M, Pieroni L, Bruckert E et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNF-alpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 2004 28 : 993 7.
12. Mercer JG, O'Reilly LM, Morgan PJ. Increasing the impact of European obesity research in preparation for the European research area: a report on the 2003 European Commission Obesity Workshop. Obes Rev 2004 5 : 79 85.
13. Wong ML, Medrano JF. Real-time PCR for mRNA quantitation. Biotechniques 2005 39 : 75 85.
14. Goulter AB, Harmer DW, Clark KL. Evaluation of low density array technology for quantitative parallel measurement of multiple genes in human tissue. BMC Genomics 2006 7 : 34.
15. Copland JA, Davies PJ, Shipley GL, Wood CG, Luxon BA, Urban RJ. The use of DNA microarrays to assess clinical samples: the transition from bedside to bench to bedside. Recent Prog Horm Res 2003 58 : 25 53.
16. Mootha VK, Lindgren CM, Eriksson KF et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003 34 : 267 73.
17. Patti ME, Butte AJ, Crunkhorn S et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003 100 : 8466 71.
18. Donahue RP, Abbott RD. Central obesity and coronary heart disease in men. Lancet 1987 2 : 1215.
19. Ducimetiere P, Richard JL. The relationship between subsets of anthropometric upper versus lower body measurements and coronary heart disease risk in middle-aged men. The Paris Prospective Study. I. Int J Obes 1989 13 : 111 21.
20. Van Harmelen V, Reynisdottir S, Eriksson P et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998 47 : 913 7.
21. Motoshima H, Wu X, Sinha MK et al. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 2002 87 : 5662 7.
22. Bastelica D, Morange P, Berthet B et al. Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arterioscler Thromb Vasc Biol 2002 22 : 173 8.
23. Lafontan M, Berlan M. Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol Sci 2003 24 : 276 83.
24. Bouloumie A, Curat CA, Sengenes C, Lolmede K, Miranville A, Busse R. Role of macrophage tissue infiltration in metabolic diseases. Curr Opin Clin Nutr Metab Care 2005 8 : 347 54.
25. Yang YS, Song HD, Li RY et al. The gene expression profiling of human visceral adipose tissue and its secretory functions. Biochem Biophys Res Commun 2003 300 : 839 46.
26. Gabrielsson BG, Johansson JM, Lonn M et al. High expression of complement components in omental adipose tissue in obese men. Obes Res 2003 11 : 699 708.
27. Ramis JM, Franssen-van Hal NL, Kramer E et al. Carboxypeptidase E and thrombospondin-1 are differently expressed in subcutaneous and visceral fat of obese subjects. Cell Mol Life Sci 2002 59 : 1960 71.
28. Vohl MC, Sladek R, Robitaille J et al. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes Res 2004 12 : 1217 22.
29. Fukuhara A, Matsuda M, Nishizawa M et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005 307 : 426 30.
30. Berndt J, Kloting N, Kralisch S et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005 54 : 2911 6.
31. Curat CA, Wegner V, Sengenes C et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006 49 : 744 7.
32. Cancello R, Tordjman J, Poitou C et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006 55 : 1554 61.
33. Ziccardi P, Nappo F, Giugliano G et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002 105 : 804 9.
34. Clement K, Viguerie N, Poitou C et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004 18 : 1657 69.
35. Clement K, Viguerie N, Diehn M et al. In vivo regulation of human skeletal muscle gene expression by thyroid hormone. Genome Res 2002 12 : 281 91.
36. Cancello R, Henegar C, Viguerie N et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005 54 : 2277 86.
37. Christiansen T, Richelsen B, Bruun JM. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond) 2005 29 : 146 50.
38. Weisberg SP, Hunter D, Huber R et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006 116 : 115 24.
39. Guerre-Millo M, Grosfeld A, Issad T. Leptin is a hypoxia-inducible gene. Obes Res 2002 10 : 856 author reply 7 8.
40. Curat CA, Miranville A, Sengenes C et al. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004 53 : 1285 92.
41. Mattusch F, Dufaux B, Heine O, Mertens I, Rost R. Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med 2000 21 : 21 4.
42. Polak J, Klimcakova E, Moro C et al. Effect of aerobic training on plasma levels and subcutaneous abdominal adipose tissue gene expression of adiponectin, leptin, interleukin 6, and tumor necrosis factor alpha in obese women. Metabolism 2006 55 : 1375 81.
43. Klimcakova E, Polak J, Moro C et al. Dynamic strength training improves insulin sensitivity without altering plasma levels and gene expression of adipokines in subcutaneous adipose tissue in obese men. J Clin Endocrinol Metab 2006 91 (12) : 5107 12.
44. Ekmekci H, Ekmekci OB. The role of adiponectin in atherosclerosis and thrombosis. Clin Appl Thromb Hemost 2006 12 : 163 8.
45. Tilg H, Hotamisligil GS. Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 2006 131 : 934 45.
46. Ballantyne GH, Gumbs A, Modlin IM. Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg 2005 15 : 692 9.
47. Garaulet M, Viguerie N, Porubsky S et al. Adiponectin gene expression and plasma values in obese women during very-low calorie diet. Relationship with cardiovascular risk factors and insulin resistance. J Clin Endocrinol Metab 2004 89 : 756 60.
48. Arvidsson E, Viguerie N, Andersson I, Verdich C, Langin D, Arner P. Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes 2004 53 : 1966 71.
49. Liu Y-M, Lacorte JM, Viguerie N et al. Adiponectin gene expression in subcutaneous adipose tissue of obese women in response to short-term very low calorie diet and refeeding. J Clin Endocrinol Metab 2003 88 : 5181 6.
50. Qi L, Doria A, Manson JE et al. Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes. Diabetes 2006 55 : 1512 6.
51. Poitou C, Viguerie N, Cancello R et al. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia 2005 48 : 519 28.
52. Yang RZ, Lee MJ, Hu H et al. Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med 2006 3 : e287.
53. Poitou C, Coussieu C, Rouault C et al. Serum amyloid A: a marker of adiposity-induced low-grade inflammation but not of metabolic status. Obesity (Silver Spring) 2006 14 : 309 18.
54. Sjoholm K, Palming J, Olofsson LE et al. A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. J Clin Endocrinol Metab 2005 90 : 2233 9.
55. Jernas M, Palming J, Sjoholm K et al. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J 2006 20 : 1540 2.
56. Poitou C, Coupaye M, Laaban JP, et al. Serum amyloid A and obstructive sleep apnea syndrome in morbidly obese subjects before and after gastric surgery. Obes Surg 2006 16 (11) : 1475 81.
57. Taleb S, Lacasa D, Bastard JP et al. Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis. FASEB J 2005 19 : 1540 2.
58. Jormsjo S, Wuttge DM, Sirsjo A et al. Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2002 161 : 939 45.
59. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998 102 : 576 83.
60. Sukhova GK, Zhang Y, Pan JH et al. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2003 111 : 897 906.
61. Liu J, Ma L, Yang J et al. Increased serum cathepsin S in patients with atherosclerosis and diabetes. Atherosclerosis 2006 186 : 411 9.
62. Taleb S, Cancello R, Poitou C et al. Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women. J Clin Endocrinol Metab 2006 91 : 1042 7.
63. Taleb S, Cancello R, Clement K, Lacasa D. Cathepsin s promotes human preadipocyte differentiation: possible involvement of fibronectin degradation. Endocrinology 2006 147 : 4950 9.
64. Xiao Y, Junfeng H, Tianhong L et al. Cathepsin K in adipocyte differentiation and its potential role of the pathogenesis of obesity. J Clin Endocrinol Metab 2006 91 (11) : 4520 7.
65. Mutch DM, Wahli W, Williamson G. Nutrigenomics and nutrigenetics: the emerging faces of nutrition. FASEB J 2005 19 : 1602 16.
66. Kussmann M, Raymond F, Affolter M. OMICS-driven biomarker discovery in nutrition and health. J Biotechnol 2006 124 : 758 87.